PRimage.jpg
FIRST REPUBLIC BANK INVESTOR ALERT: Kaplan Fox Announces Investigation of First Republic Bank on Behalf of Investors
March 16, 2023 15:57 ET | Kaplan Fox & Kilsheimer LLP
NEW YORK, March 16, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of First Republic Bank (“First Republic” or the...
axiom.png
Axiom Real-Time Metrics Attending J.P. Morgan Healthcare and Biotech Showcase Conferences
January 08, 2023 22:06 ET | Axiom Real-Time Metrics Inc
TORONTO, Jan. 08, 2023 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations,...
logo-DIACCURATE.png
Diaccurate est soutenue par Bpifrance pour son Programme DIACC2020 portant sur le développement de nouveaux composés cytotoxiques conjugués à des anticorps thérapeutiques (ADCs)
January 05, 2023 02:00 ET | DIACCURATE
La plateforme DIACC2020 ambitionne de mettre au point une nouvelle génération de composés cytotoxiques pouvant être conjugués à des anticorps thérapeutiquesElle s’appuie sur les propriétés uniques du...
logo-DIACCURATE.png
Diaccurate receives support from Bpifrance to conduct its DIACC2020 Program on the development of new payloads for antibody-drug conjugates (ADCs)
January 05, 2023 02:00 ET | DIACCURATE
The DIACC2020 platform aims to develop a new generation of cytotoxic compounds to be conjugated to therapeutic antibodies The Program stems from the unique properties of its proprietary compound...
ITM_Logo_Claim_RGB_high-res.png
ITM to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023 10:30 ET | ITM Isotope Technologies Munich SE
Garching / Munich, January 03, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that CEO Steffen Schuster and CFO Dr. Klaus Maleck will...
Agile_Logo-color on white.jpg
Agile Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 05, 2022 08:03 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and Chief Executive Officer Al Altomari will...
Agile_Logo-color on white.jpg
Agile Therapeutics to Present at the Biotech Showcase and H.C. Wainwright BioConnect Virtual Conferences
January 05, 2022 08:01 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Chairman and Chief Executive Officer Al Altomari will...
IDERA_5C_RGB-01.jpg
Idera Pharmaceuticals to Present at Upcoming Conferences
January 11, 2021 06:02 ET | Idera Pharmaceuticals, Inc.
EXTON, Pa., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced that it will provide a company outlook for 2021 at upcoming conferences. “2021 represents a...
LOGO.jpg
ROSEN, A RESPECTED LAW FIRM, Reminds JPMorgan Chase & Co. Investors of Important December 23 Deadline in Securities Class Action First Filed by the Firm; Encourages Investors with Losses in Excess of $100K to Contact Firm – JPM
November 20, 2020 18:15 ET | The Rosen Law Firm PA
NEW YORK, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of JPMorgan Chase & Co. (NYSE: JPM) between February 23, 2016...
ROSEN, LEADING INVESTOR COUNSEL, Files First Securities Class Action Lawsuit Against JPMorgan Chase & Co.; Encourages Investors with Losses Exceeding $100K to Contact the Firm – JPM
October 26, 2020 18:00 ET | The Rosen Law Firm PA
NEW YORK, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of JPMorgan...